Series
Calendar: |
12/8/2006
|
Yong-Jun Liu, MD, PhD |
Dendritic Cells and Immunity |
12/1/2006
|
Raymond P. Donnelly, PhD |
Shared Use of the IL-10 Receptor-2 Chain by IL-22 and Interferon-Lambda |
10/27/2006
|
Dr. B.J. Fowlkes |
aB T Cell Development is Regulated by the TCR and Notch Signaling Pathways |
10/20/2006
|
Dr. Zheng Cui |
Innate Cancer Immunity in Mice and Humans |
5/25/2006
|
Steven K. Libutti, MD |
Endothelial Cell Monocyte Activating Polypeptide II (EMAP-II): Mechanism of Action and Implications for Cancer Therapy |
5/19/2006
|
David Spencer, PhD |
CANCELLED--Genetically Enhanced Dendritic Cells (eDCs): Novel 3rd Generation DC Vaccine Platform Technology for Cancer |
5/5/2006
|
Stefanie Vogel, PhD |
The Innate Immune Response to Francisella tularensis LVS: Role of TLR2 |
4/14/2006
|
Dr. Suzanne Ostrand-Rosenberg |
Inflammation, Immune Suppression and Tumor Progression |
4/7/2006
|
Dr. Graham P. Pawelec |
Is It Still Worthwhile Seeking Individual Tumor Antigens for Use in Cancer Immunotherapy? |
3/17/2006
|
Dr. William George Nelson, V |
Inflammation, DNA Methylation, and the Epidemic of Prostate Cancer |
2/24/2006
|
Russell D. Salter, PhD |
Communication Between Immune Cells Mediated by Tunneling Nanotubules |
2/10/2006
|
Dr. James W. Hodge |
Vaccine Strategies and Combined Modalities for the Therapy of Cancer |
1/27/2006
|
Dr. Michael Kron |
Multifunctional Aminoacyl-tRNA Synthetases: The Way of the Parasite |
1/13/2006
|
Dr. Charles T. Lutz |
Dissecting the Onion - Multiple Layers of KIR Gene Expression Control |
1/6/2006
|
Dr. Frank Cuttitta |
Adrenomedullin - An Esoteric Growth Regulator of Human Cancers |
11/4/2005
|
James A. Lederer, PhD |
The Regulation of the Innate and Adaptive Immune Response to Injury |
10/14/2005
|
Elizabeth Kovacs, PhD |
Aging Impairs Macrophage Function After Injury |
10/7/2005
|
Dr. Ronald Schwartz |
T Cell Adaptive Tolerance |
9/16/2005
|
Dr. Linda A. Sherman |
Peripheral Tolerance of CD8 T Cells |
9/9/2005
|
Sergio Lira, MD, PhD |
Chemokines in Autoimmune Disease |
8/18/2005
|
Cheryl Dixon, PhD |
Alcohol's Effects on Hematopoiesis |
7/29/2005
|
Dr. Jeffrey Dorfman |
B Cell Memory to P. Falciparum Blood Stage Antigens in a Malaria Endemic Area |
6/30/2005
|
Peter Blumberg, PhD |
The Vanilloid Receptor as a Therapeutic Target for Pain and Inflammation |
6/10/2005
|
Dr. David Kranz |
Structure and Function Studies In Vitro Engineered, High-Affinity T Cell Receptors |
6/3/2005
|
Dr. Albert Zlotnik |
Gene Expression Analysis and the Role of Chemokines in Cancer |
5/27/2005
|
Thomas Kupper, MD |
Immunosurveillance and the Skin |
5/13/2005
|
Andrew Weinberg, PhD |
Molecular and Cellular Mechanisms that Drive Anti-OX-40-mediated Tumor Regression |
1/28/2005
|
Dr. Silvia Vidal |
Innate Resistance to Mouse Cytomegalovirus Infection is Associated With Epistatsis Between Activating Natural Killer Receptor and MHC Class I |
12/17/2004
|
Giorgio Trinchieri, M.D. |
Dendritic Cells And Their Cytokines At The Interface Of Innate Resistance and Adaptive Immunity |
11/19/2004
|
Thomas Mitchell, PhD |
Beyond Signal 2: How Do Adjuvants Boost T Cell Clonal Expansion? |
10/1/2004
|
Dr. Nicholas P. Restifo |
Translating Basic Immunology Into New Immunotherapies |
4/9/2004
|
Dr. Elizabeth Repasky (Subjeck) |
Identitication and Characterization of APO2L/TRAIL Sensitive and Resistant Patients' Tumors |
4/2/2004
|
Eric O. Long, Ph.D. |
Regulation of NK Cell Cytotoxicity by Positive and Negative Signals |
4/1/2004
|
Dr. Graham Pawelec |
Novel Immunotherapeutic Targets for Chronic Myelogenous Leukaemia |
3/19/2004
|
Dr. Marius Sudol |
The WW Domain: From the Proteomic Mapping to Signaling in Human Diseases |
2/27/2004
|
Stefanie N. Vogel, Ph.D. |
TLR4 Signaling: Turning It On and Turning It Off |
2/13/2004
|
Dr. Kerry S. Campbell |
The Inner Workings of KIR2DL4: A Potent NK Cell Activating Receptor That Works in Some of the People, Part of the Time |
9/26/2003
|
Dr. Kenneth S. Tung, University of Virginia |
Autoimmune Disease: The Interplay Between Antibody, T Cells and NK Cells |
6/13/2003
|
William G. Kerr, University of South Florida, College of Medicine |
LRBA and SHIP: Novel Targets in Cancer Therapy |
5/2/2003
|
Jenny Gumperz, PhD |
The Zen of NKT Cell Activation |
3/28/2003
|
Dr. Joan Stein-Streilein, Schepens Eye Research Institute, Boston |
"Mechanisms for the Generation of CD1d-Restricted NKT Cell Dependent CD8+ T Regulatory Cells" |
3/14/2003
|
Dr. Peter Murray, St. Jude Children's Research Hospital |
Regulation of Innate Immunity |
3/7/2003
|
Michael S. Krangel, PhD, Duke University Medical Center |
Chromatin Structure and the Developmental Regulation of V(D)J Recombination |
2/28/2003
|
Stephen Katz, MD, NIAMSD |
Mouse Models of Skin Autoimmunity and Peripheral Tolerance |
2/21/2003
|
Richard M. Ransohoff, MD |
Chemokines, Chemokine Receptors and the Nervous System: Clinical and Experimental Studies |
2/14/2003
|
Dr. Jill Suttles
|
Lipid Binding Proteins as Novel Regulators of Macrophage Gene Expression and Pro-Inflammatory Function
|
2/7/2003
|
Fred Finkelman, MD, University of Cincinnati College of Medicine |
What Stimulates the Th2 Response? |
2/7/2003
|
Fred Finkelman, M.D.
|
What Stimulates the Th2 Response? |
1/31/2003
|
Dr. Carole A. Parent, LCMB,NCI, NIH |
"Chemotaxis: Leading From Behind" |
1/24/2003
|
Thomas Rogers, Ph.D.
|
A Painful Experience: Cross-talk Between Opioid and Chemokine Receptors
|
1/24/2003
|
Thomas Rogers, PhD, Temple University School of Medicine |
A Painful Experience: Cross-talk Between Opioid and Chemokine Receptors |
1/17/2003
|
Dr. Mary Carrington, SAIC-Frederick |
Genetic Effects of KIR Genes in Human Disease |
1/17/2003
|
Dr. Mary Carrington |
Genetic Effects of KIR Genes in Human Disease |
1/3/2003
|
Dr. B.J. Fowlkes, NIAID |
Lineage Commitment in Developing T Cells |
12/13/2002
|
Dr. Thomas H. Bugge, NIDCR, NIH |
"Tumor Treatment With Protease Activated Cytotoxins" |
12/13/2002
|
Dr. Thomas H. Bugge, NIDCR, NIH |
"Tumor Treatment With Protease Activated Cytotoxins" |